CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
MyChemoCare iPad applicationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02460822
NCT02460822N/ACompleted

Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management

University of Michigan·interventional·Posted Jun 2, 2015·Updated May 11, 2017

In Brief

A clinical study evaluating MyChemoCare iPad application for Colon Cancer and Rectal Cancer. Completed, enrolled 16 participants across 1 site.

Detailed Summary

This research project addresses critical gaps in cancer symptom management through the creation of a mobile chemotherapy symptom management application. This application will assess for the presence and severity of common chemotherapy side-effects and provide personally tailored symptom-related video and narratives to enhance self-management of cancer and treatment-related symptoms. This study will examine patient acceptance and use of this mHealth application (called MyChemoCare) in a prospective trial of cancer patients (n=60) who are receiving chemotherapy for colorectal cancer at the University of Michigan Comprehensive Cancer Center.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMcKesson Foundation

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2, 2015
Enrollment StartOct 1, 2014
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 11.1 years ago

Interventions

MyChemoCare iPad applicationdevice